Adaptimmune Therapeutics shares owned by Advisor Group Holdings
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Advisor Group Holdings
from 13F filings
Historical chart of Advisor Group Holdings investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Advisor Group Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $197 | 2.1k | 0.10 |
| 2025-06-30 | $14k | 27k | 0.54 |
| 2025-03-31 | $13k | 65k | 0.20 |
| 2024-12-31 | $15k | 15k | 0.95 |
| 2024-09-30 | $15k | 15k | 0.95 |
| 2024-03-31 | $30k | 19k | 1.58 |
| 2023-12-31 | $5.0k | 6.3k | 0.79 |
| 2023-09-30 | $8.2k | 11k | 0.78 |
| 2023-06-30 | $2.1k | 2.3k | 0.92 |
| 2023-03-31 | $1.3k | 1.2k | 1.09 |
| 2022-12-31 | $2.0k | 1.2k | 1.67 |
| 2022-09-30 | $1.0k | 1.3k | 0.83 |
| 2022-06-30 | $2.1k | 1.3k | 1.67 |
| 2022-03-31 | $2.1k | 1.3k | 1.67 |
| 2021-12-31 | $5.2k | 1.3k | 4.17 |
| 2021-09-30 | $0 | 1.1k | 0.00 |
| 2021-06-30 | $0 | 50 | 0.00 |
| 2020-09-30 | $101k | 13k | 7.97 |
| 2020-03-31 | $3.0k | 1.0k | 3.00 |